BML Capital Management

BML Capital Management as of Dec. 31, 2025

Portfolio Holdings for BML Capital Management

BML Capital Management holds 16 positions in its portfolio as reported in the December 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Aclaris Therapeutics (ACRS) 37.1 $43M 14M 3.01
Atea Pharmaceuticals (AVIR) 23.1 $27M 7.5M 3.57
Oramed Pharmaceuticals Com New (ORMP) 7.8 $9.0M 3.2M 2.85
Instil Bio Com New (TIL) 6.1 $7.1M 646k 11.00
Pmv Pharmaceuticals (PMVP) 5.7 $6.6M 5.3M 1.25
CarMax (KMX) 5.2 $6.0M 155k 38.64
Kezar Life Sciences Com New (KZR) 3.9 $4.5M 721k 6.29
Target Corporation (TGT) 3.2 $3.7M 38k 97.75
Carvana Cl A Put Option (CVNA) 1.7 $2.0M 150.00 13440.00
Outset Med Com New (OM) 1.7 $2.0M 543k 3.71
Pliant Therapeutics (PLRX) 1.6 $1.9M 1.5M 1.22
Imagenebio (IMA) 1.1 $1.2M 177k 6.90
Connect Biopharma Hldgs SHS (CNTB) 1.0 $1.2M 409k 2.82
Wal-Mart Stores Put Option (WMT) 0.4 $493k 335.00 1470.00
Tesla Motors Put Option (TSLA) 0.2 $205k 1.0k 205.00
Lisata Therapeutics (LSTA) 0.1 $136k 73k 1.86